NCT05669586View on ClinicalTrials.gov

Organoids Predict Therapeutic Response in Patients With Multi-line Drug-resistant Lung Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2026

Conditions
Lung CancerOrganoid
Interventions
DRUG

Antitumor therapy guided by organoid drug sensitivity test

Antitumor therapy guided by organoid will be given to Multi-line Drug-resistant Non-small Cell Lung Cancer patients.

Trial Locations (1)

214000

RECRUITING

Affiliated Hospital of Jiangnan University, Wuxi

All Listed Sponsors
lead

Affiliated Hospital of Jiangnan University

OTHER